MA

Maat Pharma SAPAR Maat Stock Report

Last reporting period 30 Jun, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.111

Micro

Exchange

XPAR - Euronext Paris

View Section: Financials

Maat Statements

MA

Maat Income Statement

B

M

EUR (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2023-06-30
%

1.378

100

0.284

20.6

1.094

79.4

9.65

700.3

2.718

197.2

9.628

698.7

-8.534

-619.3

-0.151

-11

0.25

18.1

-8.435

-612.1

0

-8.435

-612.1

-0.758

11.131

2022-12-31
%

0.936

100

0.267

28.5

0.669

71.5

6.983

746

2.203

235.4

6.858

732.7

-6.189

-661.2

-0.091

-9.7

-0.016

-1.7

-6.296

-672.6

0

-6.296

-672.6

-0.636

9.895

2022-06-30
%

0.494

100

0.072

14.6

0.422

85.4

7.328

1483.4

2.255

456.5

7.79

1576.9

-7.368

-1491.5

-0.049

-9.9

0

-7.417

-1501.4

0

-7.417

-1501.4

-0.75

9.889

2021-12-31
%

0.587

100

0.166

28.3

0.421

71.7

4.734

806.5

1.799

306.5

5.332

908.3

-4.911

-836.6

-0.058

-9.9

-0.003

-0.5

-4.972

-847.02

0

-4.972

-847.02

-0.485

10.253

2021-06-30
%

0.385

100

0.027

7

0.358

93

4.384

1138.7

1.145

297.4

4.341

1127.5

-3.983

-1034.5

-0.063

-16.4

-0.001

-0.3

-4.047

-1051.2

0

-4.047

-1051.2

-0.425

9.515

2020-12-31
%

100

0

0

3.375

0

0.74

0

3.115

0

-3.115

0

-0.015

0

-0.003

0

-3.133

0

0

-3.133

0

-0.329

9.515

2020-06-30
%

100

0

0

2.72

0

0.55

0

2.14

0

-2.14

0

-0.03

0

0

-2.17

0

0

-2.17

0

-0.23

9.51

View Section: Balance Sheet